MARIA DE LOS DOLORES GALLARDO RINCON



DATOS GENERALES
Nombre completo   MARIA DE LOS DOLORES GALLARDO RINCON
Máximo nivel de estudios   ESPECIALIDAD
Antigüedad académica en la UNAM   5 años
NOMBRAMIENTOS
Último  PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Medicina
PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Medicina
Desde 01-01-2008 (fecha inicial de registros en el SIIA) hasta 15-03-2009
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI II2018 - 2023
* SNI I2010 - 2013

INFORMACIÓN DE PUBLICACIONES
Firmas  
Gallardo D. Gallardo Rincon, Dolores Gallardo-Rincón D. Gallardo-Rincón Ma.D. Gallardo-Rincon, Dolores Rincón D.G.
Rincon, DG
ID's SCOPUS  
6602868737
Áreas de conocimiento  
Biology Cell biology Genetics and heredity Immunology Medicine, general and internal
Medicine, research and experimental Obstetrics & gynecology Obstetrics and gynecology Oncology Pharmacology and pharmacy
Public, environmental and occupational health Biochemistry, genetics and molecular biology (miscellaneous) Genetics Internal medicine Medicine (miscellaneous)
Molecular medicine Obstetrics and gynecology Oncology Pharmaceutical science Public Health, Environmental and Occupational Health
Radiology, nuclear medicine and imaging
Coautorías con entidades de la UNAM  
Revistas en las que ha publicado  (28):
  1. Advances in Experimental Medicine and Biology, Suiza (2019)
  2. ANNALS OF ONCOLOGY, Reino Unido (2017)
  3. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, Alemania (2021)
  4. Archives Of Medical Research, México (2019)
  5. BOSNIAN J BASIC MED, Bosnia-Herzegovina (2022)
  6. CANCER CELL INTERNATIONAL, Reino Unido (2022)
  7. CANCER IMMUNOLOGY IMMUNOTHERAPY, Estados Unidos America (2017)
  8. CANCER MEDICINE, Estados Unidos America (2019)
  9. Cancer Microenvironment, Países Bajos (2019)
  10. Cells, Suiza (2021)
  11. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, Países Bajos (2022)
  12. Chinese Clinical Oncology, Hong Kong (2020)
  13. Frontiers in Genetics, Suiza (2019, 2022)
  14. Frontiers in Oncology, Suiza (2019, 2020, 2022)
  15. GACETA MEDICA DE MEXICO, México (2019, 2021)
  16. GACETA MEXICANA DE ONCOLOGIA, México (2016, 2023)
  17. Gynecologic Oncology Reports, Estados Unidos America (2018)
  18. INTERNAL MEDICINE JOURNAL, Estados Unidos America (2020)
  19. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, Estados Unidos America (2004, 2006)
  20. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, Grecia (2019)
  21. INTERNATIONAL JOURNAL OF ONCOLOGY, Grecia (2017)
  22. JOURNAL OF CLINICAL ONCOLOGY, Estados Unidos America (2011, 2012)
  23. LANCET ONCOLOGY, Estados Unidos America (2021, 2022)
  24. ONCOLOGY REPORTS, Grecia (2018)
  25. ONCOLOGY-NY, Estados Unidos America (2021)
  26. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, México (2018, 2020)
  27. SALUD PUBLICA DE MEXICO, México (2016)
  28. TRANSLATIONAL ONCOLOGY, Estados Unidos America (2020)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Resources and management for cervical cancer care are insufficient in public hospitals in MexicoCoautor: Gallardo-Rincón Ma.D., Cetina-Pérez L., Luvián-Morales J., Castro-Eguiluz D., et al.2023GACETA MEXICANA DE ONCOLOGIAWoS-id: 001106417000005
Scopus-id: 2-s2.0-85178380842
00
2The Role of Hypoxia in Endometrial Cancer2ᵒ autor: Gallardo-Rincón D., Salinas-Vera Y.M., Ruíz-García E., Silva-Cázares M.B., et al.2022CURRENT PHARMACEUTICAL BIOTECHNOLOGYWoS-id: 000737827400006
Scopus-id: 2-s2.0-85123648184
1310
3PHD finger protein 20-like protein 1 (PHF20L1) in ovarian cancer: from its overexpression in tissue to its upregulation by the ascites microenvironmentCoautor: Gallardo-Rincón D., Alberto-Aguilar D.R., Hernández-Ramírez V.I., Osorio-Trujillo J.C., et al.2022CANCER CELL INTERNATIONALWoS-id: 000739993500001
Scopus-id: 2-s2.0-85122656029
45
4Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-121ᵉʳ autor: Gallardo-Rincón D., Alamilla-García G., Montes-Servín E., Bahena-González A., et al.2022Frontiers in GeneticsWoS-id: 000813300800001
Scopus-id: 2-s2.0-85133395005
22
5Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trialCoautor: Gallardo-Rincon D., Clamp A.R., James E.C., McNeish I.A., et al.2022LANCET ONCOLOGYWoS-id: 000833519600034
Scopus-id: 2-s2.0-85133259285
2525
6Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in preventionCoautor: Gallardo-Rincón D., Pérez-Martín A.R., Castro-Eguiluz D., Cetina-Pérez L., et al.2022BOSNIAN J BASIC MEDWoS-id: 000876747500010
Scopus-id: 2-s2.0-85135075616
1010
7The health system and access to treatment in patients with cervical cancer in MexicoCoautor: Gallardo-Rincón D., Arango-Bravo E.A., Cetina-Pérez L.D.C., Galicia-Carmona T., et al.2022Frontiers in OncologyWoS-id: 000898096600001
Scopus-id: 2-s2.0-85144069360
55
8Objective responses to first-line neoadjuvant carboplatin?paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trialCoautor: Gallardo-Rincón D., Morgan R.D., McNeish I.A., Cook A.D., et al.2021LANCET ONCOLOGYWoS-id: 000615917800034
Scopus-id: 2-s2.0-85099981413
3540
9Validation of the QLQ-EN24 instrument for the assessment of health-related quality of life for women with endometrial cancer in Mexico1ᵉʳ autor: Gallardo-Rincon, Dolores, Toledo-Leyva, Alfredo, Bahena-Gonzalez, Antonio, Montes-Servin, Elizabeth, et al.2021ARCHIVES OF GYNECOLOGY AND OBSTETRICSWoS-id: 000617822000001
Scopus-id: 2-s2.0-85100888079
22
10Deciphering the long non-coding rnas and micrornas coregulation networks in ovarian cancer development: An overviewCoautor: Gallardo-Rincón D., López-Camarillo C., Ruíz-García E., Salinas-Vera Y.M., et al.2021CellsWoS-id: 000666716200001
Scopus-id: 2-s2.0-85110308119
65
11Recomendaciones sobre el tratamiento farmacológico del cáncer de ovario epitelial en México1ᵉʳ autor: Gallardo-Rincón D., Bahena-González A., Álvarez R.M., Gómez-García E.M., et al.2021GACETA MEDICA DE MEXICOWoS-id: 000752696000001
Scopus-id: 2-s2.0-85123156799
00
12Treatment of locally advanced cervical cancer with kidney failure and comorbiditiesCoautor: Gallardo-Rincón D., Arango Bravo E.A., Galicia Carmona T., Castro-Eguiluz D., et al.2021ONCOLOGY-NYWoS-id: 001096523800006
Scopus-id: 2-s2.0-85120998528
01
13Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients1ᵉʳ autor: Gallardo-Rincón D., Álvarez-Gómez R.M., Toledo-Leyva A., Montes-Servín E., et al.2020TRANSLATIONAL ONCOLOGYWoS-id: 000513932000010
Scopus-id: 2-s2.0-85076865070
1414
14Cancer-associated prothrombotic pathways: leucocytosis, but not thrombocytosis, correlates with venous thromboembolism in women with ovarian cancerCoautor: Gallardo D., López-Salazar J., Ramírez-Tirado L.A., Gómez-Contreras N., et al.2020INTERNAL MEDICINE JOURNALWoS-id: 000518098400016
Scopus-id: 2-s2.0-85080940019
44
15Corrigendum: HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells (Frontiers in Oncology, (2019), 9, 10.3389/fonc.2019.00381)2ᵒ autor: Gallardo-Rincón D., Salinas-Vera Y.M., García-Vázquez R., Hernández-de la Cruz O.N., et al.2020Frontiers in OncologyWoS-id: 000542993800001
Scopus-id: 2-s2.0-85088154245
23
16PARP inhibitors in ovarian cancer: Evidence for maintenance and treatment strategiesCoautor y autor de correspondencia: Gallardo-Rincón D., Bahena-González A., Toledo-Leyva A.2020Chinese Clinical OncologyWoS-id: 000561301300009
Scopus-id: 2-s2.0-85090173093
24
17THERAPEUTIC USE OF HUMAN PAPILLOMAVIRUS VACCINES IN CERVICAL LESIONSCoautor: Gallardo-Rincon, Dolores, Castro-Eguiluz, Denisse, Barquet-Munoz, Salim A., Arteaga-Gomez, Ana C., et al.2020REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000613899300007
Scopus-id: 2-s2.0-85093705524
23
18AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review)Coautor: Gallardo-Rincón D., Salinas-Vera Y.M., Marchat L.A., Ruiz-García E., et al.2019INTERNATIONAL JOURNAL OF MOLECULAR MEDICINEWoS-id: 000454923000002
Scopus-id: 2-s2.0-85060058753
4246
19Dietary compounds as epigenetic modulating agents in cancerCoautor: Gallardo-Rincón D., Carlos-Reyes Á., López-González J.S., Meneses-Flores M., et al.2019Frontiers in GeneticsWoS-id: 000460012900001
Scopus-id: 2-s2.0-85066610881
138164
20Hypoxamirs profiling identify miR-745 as a regulator of the early stages of vasculogenic mimicry in SKOV3 ovarian cancer cells2ᵒ autor: Gallardo-Rincón D., Salinas-Vera Y.M., García-Vázquez R., Hernández-De la Cruz O.N., et al.2019Frontiers in OncologyWoS-id: 000467873400001
Scopus-id: 2-s2.0-85067646353
2426
21Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: A STROBE compliant retrospective cohort studyCoautor: Gallardo-Rincón D., Luvián-Morales J., González-Trejo S., Carrillo J.F., et al.2019CANCER MEDICINEWoS-id: 000477017100005
Scopus-id: 2-s2.0-85068384855
3739
22Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort StudyCoautor: Gallardo-Rincón D., Beltrán L., González-Trejo S., Carmona-Herrera D.D., et al.2019Archives Of Medical ResearchWoS-id: 000478708600011
Scopus-id: 2-s2.0-85067201508
77
23Experiencia con el uso de olaparib en pacientes con cáncer de ovario1ᵉʳ autor: Gallardo-Rincón D., Alamilla-García G., Morales-Vázquez F., Cano-Blanco C., et al.2019GACETA MEDICA DE MEXICOWoS-id: 000501795700003
Scopus-id: 2-s2.0-85075959492
21
24Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer2ᵒ autor: Gallardo-Rincon, Dolores, Nunez-Olvera, I, Stephanie, Puente-Rivera, Jonathan, Salinas-Vera, Yarely M., et al.2019Frontiers in OncologyWoS-id: 000502745900001
Scopus-id: 2-s2.0-85076909476
3437
25Ascites from Ovarian Cancer Induces Novel Fucosylated ProteinsCoautor: Gallardo-Rincón D., Alberto-Aguilar D.R., Hernández-Ramírez V.I., Osorio-Trujillo J.C., et al.2019Cancer MicroenvironmentWoS-id: 000511708000008
Scopus-id: 2-s2.0-85068832682
88
26Pharmaco-epigenomics: On the road of translation medicine2ᵒ autor: Gallardo-Rincón D., López-Camarillo C., Álvarez-Sánchez M.E., Marchat L.A.2019Advances in Experimental Medicine and BiologyWoS-id: 000514075300004
Scopus-id: 2-s2.0-85074869859
1015
27let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer2ᵒ autor: Gallardo Rincon, Dolores, Garcia-Vazquez, Raul, Ruiz-Garcia, Erika, Meneses Garcia, Abelardo, et al.2018ONCOLOGY REPORTSWoS-id: 000432241900067
Scopus-id: 2-s2.0-85046336263
2023
28EFFECTS OF DIETARY COMPONENTS DURING AND AFTER CONCOMITANT CHEMORADIOTHERAPY, RADIOTHERAPY, OR SEQUENTIAL CHEMORADIOTHERAPY TO THE ABDOMINOPELVIC AREACoautor: Gallardo-Rincon, Dolores, Flores-Cisneros, Laura, Castro-Eguiluz, Denisse, Reyes-Barreter, Diana Yolanda, et al.2018REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000440876300005
Scopus-id: 2-s2.0-85052867927
65
29Advancing clinical research globally: Cervical cancer research network from Mexico2ᵒ autor: Gallardo-Rincón D., Ager B.J., de León D.C., Chávez-Blanco A., et al.2018Gynecologic Oncology ReportsWoS-id: 000441980600025
Scopus-id: 2-s2.0-85048774957
98
30Fifth ovarian cancer consensus conference of the gynecologic cancer intergroup: Recurrent diseaseCoautor: Gallardo-Rincon D., Wilson M.K., Pujade-Lauraine E., Aoki D., et al.2017ANNALS OF ONCOLOGYWoS-id: 000397622100012
Scopus-id: 2-s2.0-85018501356
211226
31MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicineCoautor: Gallardo Rincon, Dolores, Palma Flores, Carlos, Garcia-Vazquez, Raul, Ruiz-Garcia, Erika, et al.2017INTERNATIONAL JOURNAL OF ONCOLOGYWoS-id: 000400629600002
Scopus-id: 2-s2.0-85018514268
3037
32Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2?4, 20161ᵉʳ autor: Gallardo-Rincón D., Marquez J.P., Celis E.2017CANCER IMMUNOLOGY IMMUNOTHERAPYWoS-id: 000408717200013
Scopus-id: 2-s2.0-85019020238
00
33Harmonising clinical trials within the Gynecologic Cancer InterGroup: Consensus and unmet needs from the Fifth Ovarian Cancer Consensus ConferenceCoautor: Gallardo-Rincón D., Bookman M.A., Okamoto A., Stuart G., et al.2017ANNALS OF ONCOLOGYWoS-id: 000417717200006
Scopus-id: 2-s2.0-85039545602
3839
34Epidemiological overview, advances in diagnosis, prevention, treatment and management of epithelial ovarian cancer in Mexico1ᵉʳ autor: Gallardo-Rincón D., Espinosa-Romero R., Muñoz W.R., Mendoza-Martínez R., et al.2016SALUD PUBLICA DE MEXICOWoS-id: 000372689500025
Scopus-id: 2-s2.0-84969988609
55
35The challenge of immuno-oncology2ᵒ autor: Gallardo-Rincón D., Oñate Ocaña L.F., Ochoa Carrillo F.J.2016GACETA MEXICANA DE ONCOLOGIAScopus-id: 2-s2.0-84998879935
00
36Clinical findings and medical management of hereditary breast-ovarian cancer without molecular diagnosis in a referral cancer center.Coautor: Rincon, DG, Morales-Vasquez, F, Lopez-Basave, HN, Caballero, HM, et al.2012JOURNAL OF CLINICAL ONCOLOGYWoS-id: 000318009803434
00
37The relationship of polymorphism Mad1 1673 G > A on outcomes in patients with advanced ovarian cancer treated with carboplatine-paclitaxelCoautor: Rincon, DG, Santibanez, M, Prada, D, Diaz, C, et al.2011JOURNAL OF CLINICAL ONCOLOGYWoS-id: 000208880301583
00
38Elevated CA125 level associated with Meigs' syndrome: Case report and review of the literatureCoautor: Gallardo-Rincón D., Morán-Mendoza A., Alvarado-Luna G., Calderillo-Ruiz G., et al.2006INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERWoS-id: 000236269900053
Scopus-id: 2-s2.0-33645354831
3638
39Predictive factors for irresectability in advanced ovarian cancer2ᵒ autor: Rincón D.G., Martínez-Saíd H., Montes De Oca M.M., Ruiz G.C., et al.2004INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCERWoS-id: 000221794500002
Scopus-id: 2-s2.0-2942587181
1722
40Validation of the Mexican-Spanish Version of the EORTC QLQ-OV28 Instrument for the Assessment of Quality of Life in Women with Ovarian Cancer1ᵉʳ autor: Gallardo-Rincón D., Toledo-Leyva A., Bahena-González A., Montes-Servín E., et al.Archives Of Medical ResearchWoS-id: 000598650000013
Scopus-id: 2-s2.0-85089084217
43
Descargar PDF

Documentos no indexados (Humanindex)

# Título del documento ISSN Revista Año Fuente
Descargar PDF

Capítulos de libros (WoS y Scopus)

# Título del capítulo Título del libro Autores Alcance Año ISBN Fuente
1Immuno-oncology in cervical cancerCervical CancerGallardo-Rincón D., Marquez-Manriquez J.P., Ramos E., Capítulo de un Libro20179783319452319Scopus-id: 2-s2.0-85054667733
2Superficial and deep vascular lesionsBenign Disease Of The Breast: Diagnosis And TreatmentLuna-Ortiz K., Gallardo-Rincón D., Granados-Garcia M., et al.Capítulo de un Libro20149781633216495Scopus-id: 2-s2.0-84952920318
Descargar PDF

No se encuentran registros en la base de datos de obras con ISBN (Indautor).

Descargar PDF

No se encuentran registros en la base de datos de proyectos.

Descargar PDF

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Adenocarcinoma de estómago en población joven : factores pronósticos y supervivenciaTesis de EspecialidadMARIA DE LOS DOLORES GALLARDO RINCON; Calderillo Ruiz, Germán; 2019
2Factores pronósticos en pacientes con tumores germinales de ovario en el Instituto Nacional de Cancerología desde enero del 2000 hasta diciembre del 2010Tesis de EspecialidadMARIA DE LOS DOLORES GALLARDO RINCON; Aquino Mendoza, Cinthia Alejandra; 2012
Descargar PDF

No se encuentran registros en la base de datos de docencia impartida.

Descargar PDF

No se encuentran registros en la base de datos de patentes.

Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)

# Título del libro Título del capítulo ISBN Editorial Año Fuente